Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Experimental Dermatology|June 4, 2021
Target molecules for future hidradenitis suppurativa treatmentChristos C Zouboulis, John W Frew, Evangelos J Giamarellos-Bourboulis, et al.Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in miceChristian Wohn, Julia L Ober-Blöbaum, Stefan Haak, et al.Clinical and Translational Science|February 12, 2020
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy VolunteersTessa Niemeyer-van der Kolk, Salma Assil, Thomas P Buters, et al.The Journal of Investigative Dermatology|March 18, 2011
Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathwaysEmoke Rácz, Errol P Prens, Dorota Kurek, et al.Therapeutic Drug Monitoring|August 15, 2013
Monitoring antigen-specific biologics: current knowledge and future prospectsMaarten L Zandvliet, Jine S van Bezooijen, Mariska A Bos, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2011
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expressionAndrew Johnston, Xianying Xing, Andrew M Guzman, et al.Dermatology (Basel, Switzerland)|July 7, 2025
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA)Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 3, 2022
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativaThrasivoulos Tzellos, Kelsey R van Straalen, Athanassios Kyrgidis, et al.Experimental Dermatology|April 13, 2023
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteersWouter Ten Voorde, Mahdi Saghari, Jiry Boltjes, et al.The British Journal of Dermatology|February 22, 2023
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action studyKoen Dudink, Klasiena Bouwman, Yanqing Chen, et al.Pageof 10